IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i6p1035-d216141.html
   My bibliography  Save this article

Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia

Author

Listed:
  • Ping-Kun Tsai

    (Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
    Department of Internal Medicine, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung 813, Taiwan)

  • Shih-Ming Tsao

    (Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan
    School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
    Division of Chest, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan)

  • Wei-En Yang

    (Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
    Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan)

  • Chao-Bin Yeh

    (School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
    Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan)

  • Hsiang-Ling Wang

    (Department of Beauty Science, National Taichung University of Science and Technology, Taichung 404, Taiwan)

  • Shun-Fa Yang

    (Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
    Department of Medical Research, Chung Shan Medical University Hospital, Taichung 40201, Taiwan)

Abstract

The urokinase-type plasminogen activator receptor (uPAR) mediates various cellular activities and is involved in proteolysis, angiogenesis, and inflammation. The objective of this study was to investigate the association between soluble uPAR (suPAR) levels and community-acquired pneumonia (CAP) severity. A commercial enzyme-linked immunosorbent assay (ELISA) was performed to measure the plasma suPAR levels in 67 healthy controls and 75 patients with CAP. Our results revealed that plasma suPAR levels were significantly elevated in patients with CAP compared with the controls, and antibiotic treatment was effective in reducing suPAR levels. The plasma suPAR levels were correlated with the severity of CAP based on the pneumonia severity index (PSI) scores. Furthermore, lipopolysaccharide (LPS)-stimulation significantly increased uPAR expression in RAW 264.7 macrophages. In conclusion, plasma suPAR levels may play a role in the clinical assessment of CAP severity; these findings may provide information on new targets for treatment of CAP.

Suggested Citation

  • Ping-Kun Tsai & Shih-Ming Tsao & Wei-En Yang & Chao-Bin Yeh & Hsiang-Ling Wang & Shun-Fa Yang, 2019. "Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia," IJERPH, MDPI, vol. 16(6), pages 1-8, March.
    • Handle: RePEc:gam:jijerp:v:16:y:2019:i:6:p:1035-:d:216141
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/6/1035/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/16/6/1035/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:6:p:1035-:d:216141. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.